Histogen Inc a regenerative medicine company developing solutions based on the products of newborn fibroblasts today presented findings from preliminary evaluations of the Companys HGEN001 formulation during International Investigative Dermatology 2008 taking place May 1417 2008 in Kyoto...
[read full story]
Evaluations of HGEN-001 formulation indicate capabilities for new hair follicle creation and more rapid healing post-laser resurfacing. Histogen Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today presented findings from preliminary...
Evaluations of HGEN-001 formulation indicate capabilities for new hair follicle creation and more rapid healing post-laser resurfacing. Histogen Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today presented findings from preliminary...